Combining nanoparticle albumin-bound paclitaxel with camrelizumab in advanced soft tissue sarcoma: activity, safety, and future perspectives

• Main Authors: Zhichao Tian (Author), Yushen Feng (Author), Yang Yang (Author), Xu Liu (Author), Guoxin Qu (Author), Yonghao Yang (Author), Xin Wang (Author), Jiaqiang Wang (Author), Peng Zhang (Author), Weitao Yao (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: It is still uncertain whether Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) and programmed cell death protein 1 (PD-1) inhibitor have synergistic effects on metastatic soft tissue sarcomas (STSs). The purpose of this study was to evaluate the safety and activity of nab-paclitaxe...